Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
67%(2 trials)

Phase Distribution

Ph phase_4
4
80%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
4(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (20.0%)
Phase 44 (80.0%)

Trials by Status

completed360%
recruiting240%

Recent Activity

2 active trials
Showing 5 of 5
completedphase_4

Treating Caregivers Who Smoke at AFCH

NCT06051474
recruitingphase_2

E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

NCT05722561
recruitingphase_4

C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics

NCT07220356
completedphase_4

C-Raven, a Virtual Tobacco Cessation Intervention in the Community

NCT06545669
completedphase_4

Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community

NCT06289192

Clinical Trials (5)

Showing 5 of 5 trials
NCT06051474Phase 4

Treating Caregivers Who Smoke at AFCH

Completed
NCT05722561Phase 2

E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

Recruiting
NCT07220356Phase 4

C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics

Recruiting
NCT06545669Phase 4

C-Raven, a Virtual Tobacco Cessation Intervention in the Community

Completed
NCT06289192Phase 4

Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5